Jeffrey Dierks
2021
In 2021, Jeffrey Dierks earned a total compensation of $1.6M as EVP and Chief Commercial Officer at Harmony Biosciences Holdings, a 40% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $220,038 |
|---|---|
| Option Awards | $1,014,398 |
| Salary | $381,812 |
| Other | $12,027 |
| Total | $1,628,276 |
Dierks received $1M in option awards, accounting for 62% of the total pay in 2021.
Dierks also received $220K in non-equity incentive plan, $381.8K in salary and $12K in other compensation.
Rankings
In 2021, Jeffrey Dierks' compensation ranked 6,898th out of 12,406 executives tracked by ExecPay. In other words, Dierks earned more than 44.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,898 out of 12,406 | 44th |
Division Manufacturing | 3,009 out of 5,492 | 45th |
Major group Chemicals And Allied Products | 1,333 out of 2,368 | 44th |
Industry group Drugs | 1,189 out of 2,089 | 43rd |
Industry Pharmaceutical Preparations | 865 out of 1,536 | 44th |
Source: SEC filing on April 8, 2022.
Dierks' colleagues
We found five more compensation records of executives who worked with Jeffrey Dierks at Harmony Biosciences Holdings in 2021.
2021
Sandip Kapadia
Harmony Biosciences Holdings
Chief Financial Officer
2021
John Jacobs
Harmony Biosciences Holdings
Chief Executive Officer
2021
Jeffrey Dayno
Harmony Biosciences Holdings
Chief Medical Officer
2021
Andrew Serafin
Harmony Biosciences Holdings
EVP and Chief Strategy Officer
2021
Susan Drexler
Harmony Biosciences Holdings